Science & Technology22 Concepts & Facts

Gene Therapy: Viral Vectors, CRISPR-Cas9, In Vivo & Ex Vivo Biotechnology

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy

In biotechnology, molecular medicine, and clinical therapeutics, Gene Therapy represents a groundbreaking frontier of modern healthcare aimed at treating, preventing, or curing congenital genetic disorders and acquired diseases by directly altering, repairing, or replacing abnormal genetic instructions within a patient's cells. Rather than relying upon traditional pharmaceutical drugs that merely alleviate symptoms by modifying downstream proteins, gene therapy targets the root biological etiology of disease at the genomic level. By introducing functional therapeutic genes, silencing mutated overexpressed sequences, or precisely rewriting aberrant DNA base pairs, gene therapy transforms previously fatal hereditary conditions into manageable or curable disorders.

The technological execution of gene therapy operates through two primary clinical paradigms: Ex Vivo and In Vivo delivery. In Ex Vivo Gene Therapy, target cells (such as hematopoietic bone marrow stem cells or patient T-lymphocytes) are harvested directly from the patient, genetically modified in a sterile laboratory setting using therapeutic vectors, expanded in culture, and re-infused into the patient's bloodstream. This approach forms the foundation of Chimeric Antigen Receptor (CAR) T-cell therapies (such as the indigenous Indian CAR-T therapy NexCAR19 approved in 2023 for refractory lymphomas). Conversely, In Vivo Gene Therapy involves injecting therapeutic genetic material directly into the patient's body (such as into the retina or spinal canal) encapsulated within modified Viral Vectors—primarily non-pathogenic Adeno-Associated Viruses (AAV) or Lentiviruses that function as microscopic biological delivery shuttles.

The discipline experienced a revolutionary leap with the development of programmable Gene Editing technologies, most notably the CRISPR-Cas9 system pioneered by Nobel laureates Emmanuelle Charpentier and Jennifer Doudna in 2012. Derived from an ancient bacterial adaptive immune system, CRISPR uses a synthetic guide RNA (gRNA) to direct the Cas9 endonuclease enzyme to an exact genomic address, where it creates a precise double-strand break, allowing the cell's natural repair machinery to knock out defective genes or splice in healthy sequences. In medical ethics and international law, a fundamental distinction is maintained between Somatic Cell Gene Therapy (where genetic alterations are confined to the patient's body tissues and are non-heritable) and Germline Gene Therapy (which modifies reproductive gametes or embryos, creating permanent heritable changes that are strictly restricted or prohibited worldwide).

Key Concepts & Self-Assessment22 Key Facts

Review key What Is Gene Therapy and How Does It Work? exam facts and rate your mastery to track revision.

Progress: 0/22 Rated 0 Mastered 0 Review Later

Gene therapy is a clinical technique that treats or cures diseases by modifying, replacing, or repairing a patient's genetic code.

The first approved human gene therapy clinical trial was conducted in September 1990 by W. French Anderson for ADA-SCID.

Gene therapy addresses the root genetic cause of inherited disorders rather than managing secondary pharmaceutical symptoms.

Therapeutic strategies include Gene Augmentation (adding a functional gene), Gene Silencing, and Precise Gene Editing.

Viral vectors are modified viruses stripped of disease-causing genes, used as biological shuttles to deliver genes into cells.

Adeno-Associated Viruses (AAV) and Lentiviruses are the most widely utilized viral vectors in approved clinical therapies.

Non-viral gene delivery methods include Lipid Nanoparticles (LNPs), electroporation, and direct hydrodynamic injection.

In Vivo gene therapy delivers the therapeutic genetic material directly into the patient's tissue or bloodstream.

Ex Vivo gene therapy involves extracting cells, modifying them in a laboratory, and infusing the corrected cells back into the patient.

#10

CAR-T cell therapy genetically modifies a patient's T-cells with a synthetic receptor to hunt and destroy cancerous B-cells.

#11

NexCAR19, approved by CDSCO in October 2023, is India's first indigenous, low-cost CAR-T cell gene therapy for leukemia and lymphoma.

#12

CRISPR-Cas9 operates as 'molecular scissors', using guide RNA to direct the Cas9 enzyme to cut and edit exact DNA sequences.

#13

Emmanuelle Charpentier and Jennifer Doudna were awarded the 2020 Nobel Prize in Chemistry for developing the CRISPR-Cas9 method.

#14

Casgevy, approved in late 2023, is the world's first licensed CRISPR-based gene therapy for sickle cell disease and beta-thalassemia.

#15

Luxturna was the first FDA-approved in vivo gene therapy (2017), treating inherited retinal dystrophy caused by RPE65 mutations.

#16

Zolgensma is an AAV9-based in vivo gene therapy treating Spinal Muscular Atrophy (SMA) by delivering a functional SMN1 gene.

#17

Somatic cell gene therapy alters non-reproductive cells; the therapeutic genetic changes cannot be passed to future offspring.

#18

Germline gene therapy alters sperm, egg, or embryonic DNA, producing heritable genetic modifications across future generations.

#19

Germline gene editing in human embryos is prohibited by international consensus and statutory bans due to grave ethical risks.

#20

Severe Combined Immunodeficiency (SCID), hemophilia, cystic fibrosis, and Duchenne muscular dystrophy are primary targets.

#21

High manufacturing complexity makes gene therapies among the most expensive commercial medical treatments in the world.

#22

The Department of Biotechnology (DBT) and ICMR formulate statutory national ethical guidelines for gene therapy research in India.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight

Gene therapy is a modern medical technique that treats genetic disorders by altering faulty DNA sequences rather than merely managing lifelong symptoms. By delivering functional genes, silencing mutated code, or editing DNA directly, it restores healthy cellular operation. Delivery utilizes engineered vectors, typically harmless adeno-associated viruses or lipid nanoparticles, which transfer genetic material into target cells either directly inside the body or through external laboratory processing.

In UPSC Science and Technology and State PSC exams, biotechnology questions emphasize medical classifications and bioethics. Differentiate between in vivo delivery, which injects vectors directly into patients, and ex vivo therapies like CAR-T, where immune cells are modified in laboratories before reinfusion. A recurring Prelims trap concerns somatic versus germline therapy: somatic edits affect only the treated patient, whereas germline modifications alter reproductive cells and become hereditary.

Gene Therapy: Viral Vectors, CRISPR-Cas9, In Vivo & Ex Vivo Biotechnology

Key Concepts & Self-Assessment22 Key Facts

Subject Specialist Commentary

Related Knowledge Topics to Discover

Looking for more GK practice?